The FDA granted 16 spine-related device clearances in January 2018.
Spinal Tech
Globus Medical reported its 2017 fourth quarter and full-year financial results.
The global spinal implants market will grow at a compound annual growth rate of 6.6 percent through 2022, according to a Market Research Future report.
Centinel Spine extended its endorsement agreement with Performance Tech Motorsports for the 2018 IMSA WeatherTech SportsCar Championship season.
The FDA is requiring that data submitted from clinical investigations conducted outside the U.S. for medical device approval be conducted according to good clinical practice. This final rule is effective Feb. 21, 2019.
Advertisement
Spine Wave launched additional implants within its Proficient Posterior Cervical Spine System product line.
Here are 11 key notes on orthopedic and spine device companies from the past week.
Johnson & Johnson, through French affiliate Apsis S.A.S, acquired Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a robotic-assisted surgery solution.
Medtronic reported $7.3 billion in third quarter 2018 revenue, a 1 percent increase over he same period last year.
On Feb. 13, 2018, FDA Commissioner Scott Gottlieb, MD, released the FDA's budget request, which includes about $400 million in additional funding to support the development of medical technology and devices.